PTIX - Performance Technologies Inc

Day	1m	10m	60m	PreMarket	Market	AfterHours	Gap
3.05 0.21 (6.89%)	---	---	---	0.09 (2.95%)	0.19 (6.27%)	-0.01 (-0.31%)	-0.01 (-0.31%)

Protagenic Therapeutics Inc is a biopharmaceutical company focused on the discovery and development of therapeutics to treat stress-related neuropsychiatric and mood disorders. It provides treatments for mood, anxiety, depression, and neurodegenerative disorders by using peptide-based and brain-active therapeutics. The company's main compound, PT00114, is a synthetic form of Teneurin Carboxy-terminal Associated Peptide, an endogenous brain signaling peptide that can dampen overactive stress responses. It has also created a portfolio of novel neuropeptides that are in various stages of development and preclinical evaluation for the treatment of mood disorders.

Category: PHARMACEUTICAL PREPARATIONS

Market Period: Closed

Earnings & Ratios

Basic EPS:: -2.75
Diluted EPS:: -2.75
Basic P/E:: -1.1855
Diluted P/E:: -1.1855
RSI(14) 1m:: 83.33
VWAP:: 3.26
RVol:: 0.5221

Events

Period	Kind	Movement	Occurred At
1m	Price decrease 1m	3.17 -0.04 (-1.17%)	Oct 15 14:57
1m	Price decrease 1m	3.11 -0.04 (-1.3%)	Oct 15 12:22
1m	Price increase 1m	3.18 +0.06 (+1.76%)	Oct 15 11:15
10m	Price increase 10m	3.13 +0.1 (+3.3%)	Oct 15 09:38